Subscribe to RSS

DOI: 10.1055/s-0044-1787141
Evaluation of Salvia officinalis in the Treatment of Acetic Acid-induced Ulcerative Colitis in a Rat Model
Authors
Funding The authors declare that they have not received funding from agencies in the public, private, or non-profit sectors for the conduction of the present study.
Abstract
Introduction Ulcerative colitis (UC) is an inflammatory bowel disease that causes long-lasting inflammation and ulcers within the digestive tract. This study aims to determine the histochemical alteration of Salvia officinalis (sage), an anti-inflammatory and antioxidant herbal agent on UC.
Materials and Methods The disease was induced in 37 Sprague-Dawley rats with 2 mL of 3% acetic-acid (AA) enema. The rats were divided into five groups: a control group (AA), two 5-aminosalicylic (5-ASA) groups treated either orally (AO) or rectally (AR) with a dose of 100 mg/kg, and two salvia groups treated with 300mg/kg salvia orally (SO) or rectally (SR). Histopathological analyses of the colon were done on day 7, and markers such as C-reactive protein (CRP), superoxide dismutase (SOD), and complete blood count were measured.
Result In macroscopic evaluation, the AO group demonstrated the lowest involvement, followed by the SO, SR, AR, and AA groups, respectively (p = 0.01). There was no significant difference between the SO and AO groups (p = 0.10), and the SR and AR groups (p = 0.58). Regarding microscopic histopathological findings, the AO and SO group demonstrated the most satisfactory results, with no significant difference between the AO versus SO, and AR versus SR groups. Inflammation was resolved in all of the AO and SO subjects.
Conclusion Salvia can be beneficial in the treatment course of UC by inhibiting inflammatory responses, increasing the growth and viability of intestinal mucosa, and its antioxidant effects. Therefore, we propose the prescription of salvia as an adds-on or alternative therapy in the management of UC.
Ethics Approval and Consent to Participate
The present study was approved by the Medical Ethics Committee of the Shiraz University of Medical Science. The experimental protocol was approved by the Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran, and all the criteria for taking care of laboratory animals outlined in the “Guide for the Care and Use of Laboratory Animals” were applied. Ethical code: IR.SUMS.REC.1394.S1075.
Consent for Publication
Not applicable.
Availability of Data and Materials
All data regarding this study has been reported in the manuscript. Please contact the corresponding author if you are interested in any further information.
Authors' Contributions
In this study, the author contributions were as follows: Reza Shahriarirad was in charge of formal analysis, carried out investigative research, and wrote the initial manuscript draft. Sarvin Seifbehzad, Amirhossein Erfani, Fatemeh Nekouei, and Masood Hosseinzadeh contributed to the investigative research as well. Soheil Ashkani-Esfahani played a role in the study's conceptualization and oversaw project administration. Nader Tanideh was instrumental in the research concept and provided overall supervision. Omid Koohi-Hosseinabadi was responsible for developing the methodology and also engaged in investigative research. Lastly, Bahador Sarkari acted as a supervisor and was in charge of project administration.
Publication History
Received: 09 March 2024
Accepted: 09 April 2024
Article published online:
22 July 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000 Res 2020; 9: 9
- 2 Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms. Dtsch Arztebl Int 2020; 117 (33-34): 564-574
- 3 Sehgal P, Colombel JF, Aboubakr A, Narula N. Systematic review: safety of mesalazine in ulcerative colitis. Aliment Pharmacol Ther 2018; 47 (12) 1597-1609
- 4 Salice M, Rizzello F, Calabrese C, Calandrini L, Gionchetti P. A current overview of corticosteroid use in active ulcerative colitis. Expert Rev Gastroenterol Hepatol 2019; 13 (06) 557-561
- 5 Huguet M, Pereira B, Goutte M. et al. Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis. Inflamm Bowel Dis 2018; 24 (02) 261-268
- 6 Farahpour MR, Pirkhezr E, Ashrafian A, Sonboli A. Accelerated healing by topical administration of Salvia officinalis essential oil on Pseudomonas aeruginosa and Staphylococcus aureus infected wound model. Biomed Pharmacother 2020; 128: 110120
- 7 Karimzadeh S, Farahpour MR. Topical application of Salvia officinalis hydroethanolic leaf extract improves wound healing process. Indian J Exp Biol 2017; 55 (02) 98-106
- 8 Qiang Z, Ye Z, Hauck C. et al. Permeability of rosmarinic acid in Prunella vulgaris and ursolic acid in Salvia officinalis extracts across Caco-2 cell monolayers. J Ethnopharmacol 2011; 137 (03) 1107-1112
- 9 Jasicka-Misiak I, Poliwoda A, Petecka M, Buslovych O, Shlyapnikov VA, Wieczorek PP. Antioxidant phenolic compounds in Salvia officinalis L. and Salvia sclarea L. Ecological Chemistry and Engineering. 2018; 25 (01) 133
- 10 Baricevic D, Sosa S, Della Loggia R. et al. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol 2001; 75 (2-3): 125-132
- 11 Asakura H, Kitahora T. Antioxidants and polyphenols in inflammatory bowel disease: ulcerative colitis and Crohn disease. Polyphenols: prevention and treatment of human disease: Elsevier; 2018. . p. 279–92.
- 12 Charan J, Biswas T. How to calculate sample size for different study designs in medical research?. Indian J Psychol Med 2013; 35 (02) 121-126
- 13 Kaith BS, Kaith NS, Chauhan NS. Anti-inflammatory effect of Arnebia euchroma root extracts in rats. J Ethnopharmacol 1996; 55 (01) 77-80
- 14 Kaufman T, Kalderon N, Ullmann Y, Berger J. Aloe vera gel hindered wound healing of experimental second-degree burns: a quantitative controlled study. J Burn Care Rehabil 1988; 9 (02) 156-159
- 15 Fabia R, Willén R, Ar'Rajab A, Andersson R, Ahrén B, Bengmark S. Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 1992; 24 (04) 211-225
- 16 Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247 (10) 3170-3175
- 17 Millar AD, Rampton DS, Chander CL. et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996; 39 (03) 407-415
- 18 Jedidi S, Sammari H, Selmi H. et al. Strong protective effects of Salvia officinalis L. leaves decoction extract against acetic acid-induced ulcerative colitis and metabolic disorders in rat. J Funct Foods 2021; 79: 104406
- 19 Jedidi S, Aloui F, Rtibi K. et al. Individual and synergistic protective properties of Salvia officinalis decoction extract and sulfasalazine against ethanol-induced gastric and small bowel injuries. RSC Advances 2020; 10 (59) 35998-36013
- 20 Jedidi S, Selmi H, Aloui F. et al. Comparative Studies of Phytochemical Screening, HPLC-PDA-ESI-MS/MS-LC/HR-ESI-MS Analysis, Antioxidant Capacity and in Vitro Fermentation of Officinal Sage (Salvia officinalis L.) Cultivated in Different Biotopes of Northwestern Tunisia. Chem Biodivers 2020; 17 (01) e1900394
- 21 Jalalipour M, Yegdaneh A, Talebi A, Minaiyan M. Salvia officinalis leaf extracts protect against acute colitis in rats. Res Pharm Sci 2022; 17 (04) 350-359
- 22 Mascolo N, Izzo AA, Autore G, Maiello FM, Di Carlo G, Capasso F. Acetic acid-induced colitis in normal and essential fatty acid deficient rats. J Pharmacol Exp Ther 1995; 272 (01) 469-475
- 23 Mahdavi NS, Talebi A, Minaiyan M. Ameliorative effect of galantamine on acetic acid-induced colitis in rats. Res Pharm Sci 2019; 14 (05) 391-399
- 24 Nzeusseu Toukap A, Delporte C, Noyon C. et al. Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis. Free Radic Res 2014; 48 (04) 461-465
- 25 Jedidi S, Selmi H, Aloui F. et al. Antioxidant Properties, Phytoactive Compounds and Potential Protective Action of Salvia officinalis Flowers Against Combined Gastro-Intestinal Ulcer and Diarrhea Experimentally Induced in Rat. Dose Response 2022; 20 (02) 15 593258221102313
- 26 Head KA, Jurenka JS. Inflammatory bowel disease Part 1: ulcerative colitis–pathophysiology and conventional and alternative treatment options. Altern Med Rev 2003; 8 (03) 247-283
- 27 Ghorbani A, Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J Tradit Complement Med 2017; 7 (04) 433-440
- 28 Klotz U, Schwab M. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Deliv Rev 2005; 57 (02) 267-279
- 29 Mohammed HA, Eldeeb HM, Khan RA. et al. Sage, Salvia officinalis L., Constituents, hepatoprotective activity, and cytotoxicity evaluations of the essential oils obtained from fresh and differently timed dried herbs: a comparative analysis. Molecules 2021; 26 (19) 5757
- 30 Pedro DF, Ramos AA, Lima CF, Baltazar F, Pereira-Wilson C. Colon Cancer Chemoprevention by Sage Tea Drinking: Decreased DNA Damage and Cell Proliferation. Phytother Res 2016; 30 (02) 298-305
- 31 Nishitani Y, Yamamoto K, Yoshida M. et al. Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors 2013; 39 (05) 522-533
- 32 Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018; 9: 754
- 33 DeRoche TC, Xiao SY, Liu X. Histological evaluation in ulcerative colitis. Gastroenterol Rep (Oxf) 2014; 2 (03) 178-192
- 34 Rana SV, Sharma S, Prasad KK, Sinha SK, Singh K. Role of oxidative stress & antioxidant defence in ulcerative colitis patients from north India. Indian J Med Res 2014; 139 (04) 568-571
- 35 Kontogianni VG, Tomic G, Nikolic I. et al. Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity. Food Chem 2013; 136 (01) 120-129
- 36 Seguí J, Gil F, Gironella M. et al. Down-regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis. Inflamm Bowel Dis 2005; 11 (10) 872-882
- 37 Abdollahi A, Adelibahram F, Ghassab-Abdollahi N, Araj-Khodaei M, Parsian Z, Mirghafourvand M. The effect of Salvia officinalis on blood glycemic indexes and blood lipid profile in diabetic patients: a systematic review and meta-analysis. J Complement Integr Med 2022; 20 (03) 521-529
- 38 Koubaa-Ghorbel F, Chaâbane M, Turki M, Makni-Ayadi F, El Feki A. The protective effects of Salvia officinalis essential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high-fat diet. J Food Biochem 2020; 44 (04) e13160
- 39 Lima CF, Andrade PB, Seabra RM, Fernandes-Ferreira M, Pereira-Wilson C. The drinking of a Salvia officinalis infusion improves liver antioxidant status in mice and rats. J Ethnopharmacol 2005; 97 (02) 383-389
- 40 Sharma Y, Fagan J, Schaefer J. Ethnobotany, phytochemistry, cultivation and medicinal properties of Garden sage (Salvia officinalis L.). J Pharmacogn Phytochem 2019; 8 (03) 3139-3148
